Pfizer receives subpoenas in U.S. intravenous saline solution probe

BOSTON, April 19 (Reuters) - Pfizer Inc said on Wednesday that the company had received grand jury subpoenas from the U.S. Justice Department amid an antitrust investigation focused on drugmakers that market intravenous saline solution.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.